ICU Medical (NASDAQ: ICUI) — Perfil da empresa, notícias e dados financeiros
ICU Medical develops innovative medical devices for infusion therapy, ensuring safety and improving patient outcomes.
ICU Medical
ICU Medical (NASDAQ:ICUI) specializes in the development, manufacture, and sale of innovative medical devices used in infusion therapy, oncology, and critical care applications. Their portfolio includes IV solutions, sets, connectors, and related accessories designed to ensure patient safety and improve clinical outcomes. ICU Medical is committed to enhancing patient care by offering products that help clinicians to deliver safe, efficient, and effective treatments. Objectives of the company focus on continuous innovation, expanding their product range to meet healthcare needs, and maintaining high standards of quality and safety in all their offerings.
Resumo
Operações
Produtos e/ou serviços de ICU Medical
- IV solutions and therapy systems designed to deliver fluids and drugs in hospitals and clinics.
- Infusion pumps and accessories for controlled delivery of fluids and medications.
- IV connectors and extensions aimed at reducing infection risks.
- Oncology products for the safe preparation and delivery of chemotherapy drugs.
- Critical care products, including hemodynamic monitoring systems to track patient vital signs.
- Custom IV therapy sets tailored to specific healthcare provider needs, enhancing efficiency and patient care.
equipe executiva do ICU Medical
- Vivek JainCEO & Chairman of the Board
- Daniel WoolsonPresident
- Brian Michael BonnellCFO & Treasurer
- Christian B. VoigtlanderChief Operating Officer
- Virginia Ruth SanzoneCorporate VP, General Counsel, Secretary & Compliance Officer
- Ben SousaChief Information Officer
- Olivia BarrallVice President of Human Resources
Histórico de dividendos
Dividendos por ação pagos pela ICU Medical, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2002 | — | — | — | $1.5000 |
Principais indicadores financeiros
Resultados divulgados pela ICU Medical, em USD.
- Cap. de mercado
- 4,2 bi
- Receita (TTM)
- 2,2 bi
- P/L
- 139.8
- LPA (diluído, TTM)
- 1.2
- Dividend yield
- —
- Margem de lucro
- 1.4%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2,2 bi | 107 mi | 732 mil | |
| 2,4 bi | 43 mi | -117,7 mi | |
| 2,3 bi | 22,8 mi | -29,7 mi | |
| 2,3 bi | -42,9 mi | -74,3 mi |